On this episode of Healthy Outcomes, our host Mark Ross interviews Sherri Faber, president and CEO of 340B Compliance Partners. Together, they discuss the 340B Drug Pricing Program (340B Program), a federal government program created in 1992 that requires pharmaceutical manufacturers to provide outpatient pharmaceuticals to eligible healthcare providers and covered entities at discounted prices.
Topics of discussion include:
Connect with us to hear more about our healthcare team.
Sherri Faber is the president and CEO of 340B Compliance Partners and has nearly 30 years of experience in the healthcare industry. Prior to her current role, Sherri served as a director of pharmacy for more than a decade and is an Apexus 340B advanced operations certified expert, serving as a past speaker on 340B audits at a multi-state pharmacy conference.